MYOV—My largest position among small bios right now... I think the endometriosis opportunity is underappreciated - it should do much better than [ABBV’s] Orlissa.
How big do you think the endometriosis market is (US and worldwide)? What market share in endometriosis do you expect Relugolix to capture? What’s the status of the ex-US clinical program? TIA
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”